Mailing Recommendations to the Individual or Physician to Increase Screening for Type 2 Diabetes in Women With Previous Gestational Diabetes: Clinical Trial.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 268
- 试验地点
- 2
- 主要终点
- The proportion of patients screened in each group
研究概览
简要总结
In 1998, The Canadian Diabetes Association published guidelines that recommended women diagnosed with gestational diabetes mellitus (GDM,) should be screened postpartum for Type 2 diabetes using a glucose tolerance test. We determined the rate of screening for Type 2 diabetes at the Ottawa Hospital before and after the publication of this guideline and found that none of the women in either period had been screened following this recommendation. We believe a reminder letter outlining the recommended screening test sent to the patient and/or her family physician would increase screening for Type 2 diabetes in women with previous GDM.
详细描述
In 1998, the Canadian Diabetes Association (CDA) published guidelines that recommended all women diagnosed with gestational diabetes mellitus (GDM) should be screened 6 weeks to 6 months postpartum for type 2 diabetes mellitus (DM) using a 2-hour 75g oral glucose tolerance test. We determined the rate of screening for type 2 DM at the Ottawa Hospital before and after the publication of this guideline and found that none of the women in either period had been screened following the CDA guideline recommendations although other screening tests that had not been recommended had increased in utilization. Since the publication of the CDA guidelines several studies have been published that demonstrate that identification of patients with an abnormal oral glucose tolerance test and early treatment prevents the onset of diabetes. This research and the recommendations need to be communicated to physicians.
Methods:
Overall Objectives:
- To test whether a reminder letter outlining the screening recommendations that is sent both to the patient and her family physician would increase screening postpartum for type 2 DM in women with previous GDM more than a letter sent only to the physician or the patient.
- To determine the patient and physician barriers that are impeding the adoption of this recommended screening strategy.
Setting:
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Factorial
- 盲法
- None
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •All women, who are pregnant and attend the High Risk Pregnancy Unit and who have been diagnosed with Gestational Diabetes will be considered for inclusion in the study.
排除标准
- •Patient does not have a Family Physician
- •Patient's Family Physician already has a patient enrolled in the study
- •Patient already enrolled in the study for a previous pregnancy
- •Unable to give informed consent in English or French
- •History of pre-gestational diabetes mellitus
- •Intra-uterine fetal death or still birth
结局指标
主要结局
The proportion of patients screened in each group
次要结局
未报告次要终点